Literature DB >> 22952059

Female mice are more susceptible to nonalcoholic fatty liver disease: sex-specific regulation of the hepatic AMP-activated protein kinase-plasminogen activator inhibitor 1 cascade, but not the hepatic endotoxin response.

Astrid Spruss1, Janin Henkel, Giridhar Kanuri, Daniela Blank, Gerhard P Püschel, Stephan C Bischoff, Ina Bergheim.   

Abstract

As significant differences between sexes were found in the susceptibility to alcoholic liver disease in human and animal models, it was the aim of the present study to investigate whether female mice also are more susceptible to the development of non-alcoholic fatty liver disease (NAFLD). Male and female C57BL/6J mice were fed either water or 30% fructose solution ad libitum for 16 wks. Liver damage was evaluated by histological scoring. Portal endotoxin levels and markers of Kupffer cell activation and insulin resistance, plasminogen activator inhibitor 1 (PAI-1) and phosphorylated adenosine monophosphate-activated protein kinase (pAMPK ) were measured in the liver. Adiponectin mRNA expression was determined in adipose tissue. Hepatic steatosis was almost similar between male and female mice; however, inflammation was markedly more pronounced in livers of female mice. Portal endotoxin levels, hepatic levels of myeloid differentiation primary response gene (88) (MyD88) protein and of 4-hydroxynonenal protein adducts were elevated in animals with NAFLD regardless of sex. Expression of insulin receptor substrate 1 and 2 was decreased to a similar extent in livers of male and female mice with NAFLD. The less pronounced susceptibility to liver damage in male mice was associated with a superinduction of hepatic pAMPK in these mice whereas, in livers of female mice with NAFLD, PAI-1 was markedly induced. Expression of adiponectin in visceral fat was significantly lower in female mice with NAFLD but unchanged in male mice compared with respective controls. In conclusion, our data suggest that the sex-specific differences in the susceptibility to NAFLD are associated with differences in the regulation of the adiponectin-AMPK-PAI-1 signaling cascade.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22952059      PMCID: PMC3521787          DOI: 10.2119/molmed.2012.00223

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  46 in total

Review 1.  Dietary fructose and intestinal barrier: potential risk factor in the pathogenesis of nonalcoholic fatty liver disease.

Authors:  Astrid Spruss; Ina Bergheim
Journal:  J Nutr Biochem       Date:  2009-09       Impact factor: 6.048

2.  Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene.

Authors:  E Araki; M A Lipes; M E Patti; J C Brüning; B Haag; R S Johnson; C R Kahn
Journal:  Nature       Date:  1994-11-10       Impact factor: 49.962

3.  Estrogen is involved in early alcohol-induced liver injury in a rat enteral feeding model.

Authors:  M Yin; K Ikejima; M D Wheeler; B U Bradford; V Seabra; D T Forman; N Sato; R G Thurman
Journal:  Hepatology       Date:  2000-01       Impact factor: 17.425

Review 4.  Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.

Authors:  D Shyangdan; C Clar; N Ghouri; R Henderson; T Gurung; D Preiss; N Sattar; A Fraser; N Waugh
Journal:  Health Technol Assess       Date:  2011-11       Impact factor: 4.014

Review 5.  Review: The role of insulin resistance in nonalcoholic fatty liver disease.

Authors:  Kristina M Utzschneider; Steven E Kahn
Journal:  J Clin Endocrinol Metab       Date:  2006-09-12       Impact factor: 5.958

6.  Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice.

Authors:  Michihiro Mutoh; Naoya Teraoka; Shinji Takasu; Mami Takahashi; Kunishige Onuma; Masafumi Yamamoto; Naoto Kubota; Takamoto Iseki; Takashi Kadowaki; Takashi Sugimura; Keiji Wakabayashi
Journal:  Gastroenterology       Date:  2011-02-18       Impact factor: 22.682

7.  Current treatment strategies for non-alcoholic fatty liver disease (NAFLD).

Authors:  Poonam Mishra; Zobair M Younossi
Journal:  Curr Drug Discov Technol       Date:  2007-08

8.  Estrogens protect against high-fat diet-induced insulin resistance and glucose intolerance in mice.

Authors:  Elodie Riant; Aurélie Waget; Haude Cogo; Jean-François Arnal; Rémy Burcelin; Pierre Gourdy
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

9.  Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice.

Authors:  Yan Y Lam; Connie W Y Ha; Craig R Campbell; Andrew J Mitchell; Anuwat Dinudom; Jan Oscarsson; David I Cook; Nicholas H Hunt; Ian D Caterson; Andrew J Holmes; Len H Storlien
Journal:  PLoS One       Date:  2012-03-23       Impact factor: 3.240

10.  Obesity, Visceral Fat, and NAFLD: Querying the Role of Adipokines in the Progression of Nonalcoholic Fatty Liver Disease.

Authors:  M S Mirza
Journal:  ISRN Gastroenterol       Date:  2011-08-28
View more
  32 in total

1.  High fat diet feeding results in gender specific steatohepatitis and inflammasome activation.

Authors:  Michal Ganz; Timea Csak; Gyongyi Szabo
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

2.  Moderate alcohol consumption diminishes the development of non-alcoholic fatty liver disease (NAFLD) in ob/ob mice.

Authors:  Giridhar Kanuri; Marianne Landmann; Josephine Priebs; Astrid Spruss; Marina Löscher; Doreen Ziegenhardt; Carolin Röhl; Christian Degen; Ina Bergheim
Journal:  Eur J Nutr       Date:  2015-05-24       Impact factor: 5.614

Review 3.  Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps.

Authors:  Amedeo Lonardo; Fabio Nascimbeni; Stefano Ballestri; DeLisa Fairweather; Sanda Win; Tin A Than; Manal F Abdelmalek; Ayako Suzuki
Journal:  Hepatology       Date:  2019-09-23       Impact factor: 17.425

4.  Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).

Authors:  Cathrin Sellmann; Cheng Jun Jin; Anna Janina Engstler; Jean-Pascal De Bandt; Ina Bergheim
Journal:  Eur J Nutr       Date:  2016-08-05       Impact factor: 5.614

5.  High-Fructose Intake Impairs the Hepatic Hypolipidemic Effects of a High-Fat Fish-Oil Diet in C57BL/6 Mice.

Authors:  Joshua S Wooten; Tayler N Nick; Andrew Seija; Kaylee E Poole; Kelsey B Stout
Journal:  J Clin Exp Hepatol       Date:  2016-09-08

6.  Induction of steatohepatitis (NASH) with insulin resistance in wildtype B6 mice by a western-type diet containing soybean oil and cholesterol.

Authors:  Janin Henkel; Charles Dominic Coleman; Anne Schraplau; Korinna Jӧhrens; Daniela Weber; José Pedro Castro; Martin Hugo; Tim Julius Schulz; Stephanie Krämer; Annette Schürmann; Gerhard Paul Püschel
Journal:  Mol Med       Date:  2017-03-21       Impact factor: 6.354

7.  Time-dependent behavioral, neurochemical, and metabolic dysregulation in female C57BL/6 mice caused by chronic high-fat diet intake.

Authors:  Saritha Krishna; Zhoumeng Lin; Claire B de La Serre; John J Wagner; Donald H Harn; Lacey M Pepples; Dylan M Djani; Matthew T Weber; Leena Srivastava; Nikolay M Filipov
Journal:  Physiol Behav       Date:  2016-02-04

8.  Sex hormone affects the severity of non-alcoholic steatohepatitis through the MyD88-dependent IL-6 signaling pathway.

Authors:  Guangda Xin; Shaoyou Qin; Song Wang; Xu Wang; Yonggui Zhang; Jiangbin Wang
Journal:  Exp Biol Med (Maywood)       Date:  2015-03-18

9.  Diet high in fructose promotes liver steatosis and hepatocyte apoptosis in C57BL/6J female mice: Role of disturbed lipid homeostasis and increased oxidative stress.

Authors:  Youngshim Choi; Mohamed A Abdelmegeed; Byoung-Joon Song
Journal:  Food Chem Toxicol       Date:  2017-03-01       Impact factor: 6.023

10.  Liver-specific GH receptor gene-disrupted (LiGHRKO) mice have decreased endocrine IGF-I, increased local IGF-I, and altered body size, body composition, and adipokine profiles.

Authors:  Edward O List; Darlene E Berryman; Kevin Funk; Adam Jara; Bruce Kelder; Feiya Wang; Michael B Stout; Xu Zhi; Liou Sun; Thomas A White; Nathan K LeBrasseur; Tamara Pirtskhalava; Tamara Tchkonia; Elizabeth A Jensen; Wenjuan Zhang; Michal M Masternak; James L Kirkland; Richard A Miller; Andrzej Bartke; John J Kopchick
Journal:  Endocrinology       Date:  2014-02-11       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.